Clinical Trials Logo

Clinical Trial Summary

This study is investigating whether eye exercises for abducens palsy and internuclear ophthalmoplegia increase ocular range of motion in the paretic direction when performed in virtual reality under head-cancelled compared to head-active conditions.


Clinical Trial Description

Participants with abducens palsy or internuclear ophthalmoplegia, two common types of ocular cranial nerve palsies, will perform 3 different tasks in virtual reality under head-cancelled and head-active conditions. Head active is the normal state, where gaze can be shifted by moving the head, the eyes, or a combination of the two. Head-cancelled refers to the condition where the scene moves with the head, rendering head movement ineffective to shift gaze. In this condition, the eyes must move in order to shift gaze. The hypothesis is that this requirement for eye movement will result in larger eye movements, which could be therapeutic. The tasks performed under the two conditions will include horizontal transposition of coins, repetitive horizontal saccades, and game play. The primary analysis will be a within subject's comparison of eye movement amplitude in head-cancelled (experimental) versus head-active (control) conditions. Additionally, as a control comparison for secondary analysis, a group with normal vision will also perform the tasks under both conditions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06417216
Study type Interventional
Source University of Massachusetts, Worcester
Contact Kevin Houston, OD
Phone 7744418745
Email kevin.houston@umassmed.edu
Status Recruiting
Phase N/A
Start date June 1, 2024
Completion date June 1, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05338450 - Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis Phase 3
Completed NCT02391961 - Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis Phase 2